| Primary |
| Hypertension |
16.6% |
| Product Used For Unknown Indication |
10.9% |
| Gastrooesophageal Reflux Disease |
9.1% |
| Osteoarthritis |
6.3% |
| Dyspepsia |
5.7% |
| Prophylaxis Against Gastrointestinal Ulcer |
5.7% |
| Constipation |
4.6% |
| Gastric Ulcer |
4.6% |
| Peptic Ulcer |
4.6% |
| Diabetes Mellitus |
4.0% |
| Peptic Ulcer Haemorrhage |
4.0% |
| Helicobacter Infection |
3.4% |
| Central Nervous System Inflammation |
2.9% |
| Cns Ventriculitis |
2.9% |
| Gastritis |
2.9% |
| Reflux Oesophagitis |
2.9% |
| Gouty Arthritis |
2.3% |
| Hiatus Hernia |
2.3% |
| Hyperlipidaemia |
2.3% |
| Insomnia |
2.3% |
|
| Vomiting |
13.0% |
| Drug Ineffective |
7.4% |
| Gastric Cancer |
7.4% |
| Inappropriate Antidiuretic Hormone Secretion |
7.4% |
| Lung Neoplasm Malignant |
5.6% |
| Oesophagitis |
5.6% |
| Pyelonephritis |
5.6% |
| Acute Psychosis |
3.7% |
| Adverse Event |
3.7% |
| Colitis |
3.7% |
| Diarrhoea |
3.7% |
| Hypertension |
3.7% |
| Hyponatraemia |
3.7% |
| Liver Function Test Abnormal |
3.7% |
| Neuroendocrine Tumour |
3.7% |
| Palpitations |
3.7% |
| Rash Erythematous |
3.7% |
| Tachyarrhythmia |
3.7% |
| Tetany |
3.7% |
| Tremor |
3.7% |
|
| Secondary |
| Drug Use For Unknown Indication |
29.7% |
| Product Used For Unknown Indication |
29.0% |
| Hypertension |
7.8% |
| Gastrooesophageal Reflux Disease |
3.9% |
| Renal Transplant |
3.0% |
| Back Pain |
2.4% |
| Osteoporosis |
2.3% |
| Pain |
2.3% |
| Depression |
2.2% |
| Helicobacter Infection |
2.0% |
| Epilepsy |
1.8% |
| Gastritis |
1.7% |
| Hiv Infection |
1.7% |
| Rheumatoid Arthritis |
1.7% |
| Essential Hypertension |
1.6% |
| Abdominal Pain Lower |
1.4% |
| Anxiety |
1.4% |
| Barrett's Oesophagus |
1.4% |
| Multiple Drug Overdose Intentional |
1.4% |
| Nausea |
1.4% |
|
| Thrombocytopenia |
12.0% |
| Vomiting |
10.0% |
| Status Epilepticus |
8.7% |
| Hyponatraemia |
6.7% |
| Jaundice |
6.7% |
| Rhabdomyolysis |
6.7% |
| Urticaria |
5.3% |
| Completed Suicide |
4.7% |
| Agranulocytosis |
4.0% |
| Stevens-johnson Syndrome |
4.0% |
| Toxic Skin Eruption |
4.0% |
| Femur Fracture |
3.3% |
| Neutropenia |
3.3% |
| Renal Failure Acute |
3.3% |
| Stillbirth |
3.3% |
| Weight Increased |
3.3% |
| Dystonia |
2.7% |
| Impaired Healing |
2.7% |
| Rash Maculo-papular |
2.7% |
| Renal Failure |
2.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
40.3% |
| Product Used For Unknown Indication |
17.2% |
| Rheumatoid Arthritis |
8.3% |
| Hypertension |
5.4% |
| Crohn's Disease |
3.5% |
| Gastrooesophageal Reflux Disease |
3.5% |
| Pain |
3.3% |
| Prophylaxis |
2.7% |
| Depression |
1.8% |
| Diabetes Mellitus |
1.8% |
| Vitamin Supplementation |
1.6% |
| Osteoporosis |
1.5% |
| Nausea |
1.3% |
| Asthma |
1.2% |
| Multiple Myeloma |
1.2% |
| Hiv Infection |
1.2% |
| Blood Cholesterol Increased |
1.1% |
| Hypercholesterolaemia |
1.0% |
| Psoriatic Arthropathy |
1.0% |
| Hypothyroidism |
1.0% |
|
| Vomiting |
14.1% |
| Pyrexia |
7.9% |
| Urinary Tract Infection |
5.3% |
| Sepsis |
5.2% |
| Nausea |
5.0% |
| Pneumonia |
4.9% |
| Renal Failure Acute |
4.9% |
| Pruritus |
4.7% |
| Flushing |
4.6% |
| Injection Site Pain |
4.6% |
| Rhabdomyolysis |
4.4% |
| Weight Decreased |
4.4% |
| Accidental Exposure |
4.1% |
| Weight Increased |
4.1% |
| Thrombocytopenia |
4.0% |
| Respiratory Failure |
3.7% |
| Incorrect Dose Administered |
3.6% |
| White Blood Cell Count Decreased |
3.6% |
| Pain |
3.5% |
| Pulmonary Embolism |
3.4% |
|
| Interacting |
| Drug Use For Unknown Indication |
45.7% |
| Pain |
8.5% |
| Asthma |
6.4% |
| Gastrooesophageal Reflux Disease |
4.3% |
| Convulsion |
3.2% |
| Hypercholesterolaemia |
3.2% |
| Hypertension |
3.2% |
| Routine Health Maintenance |
3.2% |
| Anxiety |
2.1% |
| Constipation |
2.1% |
| Convulsion Prophylaxis |
2.1% |
| Epilepsy |
2.1% |
| Hyperlipidaemia |
2.1% |
| Hypothyroidism |
2.1% |
| Menopausal Disorder |
2.1% |
| Neuropathy Peripheral |
2.1% |
| Sleep Disorder |
2.1% |
| Abdominal Discomfort |
1.1% |
| Back Pain |
1.1% |
| Bacterial Infection |
1.1% |
|
| Prescribed Overdose |
20.0% |
| Discomfort |
6.7% |
| Drug Effect Decreased |
6.7% |
| Drug Interaction |
6.7% |
| Flushing |
6.7% |
| Hyponatraemia |
6.7% |
| Leukocytosis |
6.7% |
| Overdose |
6.7% |
| Rash |
6.7% |
| Renal Function Test Abnormal |
6.7% |
| Restlessness |
6.7% |
| Rhabdomyolysis |
6.7% |
| Thrombocytopenia |
6.7% |
|
